ATE286536T1 - Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen - Google Patents

Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen

Info

Publication number
ATE286536T1
ATE286536T1 AT94929779T AT94929779T ATE286536T1 AT E286536 T1 ATE286536 T1 AT E286536T1 AT 94929779 T AT94929779 T AT 94929779T AT 94929779 T AT94929779 T AT 94929779T AT E286536 T1 ATE286536 T1 AT E286536T1
Authority
AT
Austria
Prior art keywords
plasmodium
vivax
binding
binding domains
polypeptides
Prior art date
Application number
AT94929779T
Other languages
English (en)
Inventor
Kin Lee Sim
Chetan Chitnis
Louis H Miller
David S Peterson
Xin-Zhuan Su
Thosmas E Wellems
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE286536T1 publication Critical patent/ATE286536T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94929779T 1993-09-10 1994-09-07 Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen ATE286536T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11967793A 1993-09-10 1993-09-10
PCT/US1994/010230 WO1995007353A2 (en) 1993-09-10 1994-09-07 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins

Publications (1)

Publication Number Publication Date
ATE286536T1 true ATE286536T1 (de) 2005-01-15

Family

ID=22385690

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929779T ATE286536T1 (de) 1993-09-10 1994-09-07 Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen

Country Status (9)

Country Link
US (3) US5849306A (de)
EP (1) EP0719333B1 (de)
JP (1) JPH09502353A (de)
CN (3) CN1134173A (de)
AT (1) ATE286536T1 (de)
AU (1) AU694142B2 (de)
CA (1) CA2171193A1 (de)
DE (1) DE69434221T2 (de)
WO (1) WO1995007353A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2171193A1 (en) 1993-09-10 1995-03-16 Kim Lee Sim Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
US5993827A (en) * 1993-09-10 1999-11-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
SE9703386D0 (sv) * 1997-09-19 1997-09-19 Karolinska Innovations Ab Malaria polypeptides
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US7025961B1 (en) 1999-03-04 2006-04-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-plasmodium composition and methods of use
WO2000052056A2 (en) * 1999-03-04 2000-09-08 Entremed, Inc. Anti-plasmodium compositions and methods of use
AU2004201615B2 (en) * 1999-03-04 2007-01-25 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-plasmodium compositions and methods of use
US20020127241A1 (en) * 2000-08-07 2002-09-12 Narum David L. Anti-plasmodium compositions and methods of use
WO2002078603A2 (en) * 2001-04-02 2002-10-10 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
DE60219340T2 (de) * 2001-10-15 2007-12-13 National Institute Of Agrobiological Sciences, Tsukuba Antimikrobielle proteine, für die proteine codierende gene und verfahren zu deren anwendung
AU2002365202A1 (en) * 2001-11-09 2003-09-02 Entremed, Inc. Synthetic genes for malarial proteins and methods of use
CA2657353A1 (en) * 2006-07-18 2008-01-24 Glaxosmithkline Biologicals S.A. Vaccines for malaria
US7773575B2 (en) * 2006-07-24 2010-08-10 Harris Corporation System and method for communicating using a plurality of TDMA mesh networks having efficient bandwidth use
CN101921337B (zh) * 2010-07-21 2013-05-08 上海市疾病预防控制中心 间日疟原虫乳酸脱氢酶抗体、相关制备方法、杂交瘤细胞株和应用
US8784832B2 (en) 2011-08-19 2014-07-22 University Of South Florida (A Florida Non-Profit Corporation) Synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein
CN110343161B (zh) * 2019-07-30 2021-08-20 暨南大学 一种检测恶性疟原虫hrp2和间日疟原虫ldh的结合蛋白组合及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5144007A (en) * 1988-11-03 1992-09-01 La Jolla Cancer Research Foundation Thyroid hormone receptor
US5198347A (en) * 1990-07-20 1993-03-30 The United States Of America As Represented By The Department Of Health And Human Services Dna encoding plasmodium vivax and plasmodium knowlesi duffy receptor
EP0630407B1 (de) * 1992-03-11 2000-08-02 PRENDERGAST, Kenneth, Francis Anti-virale Fusionspeptide
US5993827A (en) * 1993-09-10 1999-11-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
CA2171193A1 (en) * 1993-09-10 1995-03-16 Kim Lee Sim Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins

Also Published As

Publication number Publication date
US6392026B1 (en) 2002-05-21
EP0719333A1 (de) 1996-07-03
WO1995007353A3 (en) 1995-06-01
AU7872194A (en) 1995-03-27
CN1414102A (zh) 2003-04-30
CA2171193A1 (en) 1995-03-16
HK1010395A1 (en) 1999-06-17
CN1134173A (zh) 1996-10-23
DE69434221T2 (de) 2006-01-19
US5849306A (en) 1998-12-15
WO1995007353A2 (en) 1995-03-16
AU694142B2 (en) 1998-07-16
JPH09502353A (ja) 1997-03-11
US20020169305A1 (en) 2002-11-14
DE69434221D1 (de) 2005-02-10
US6962987B2 (en) 2005-11-08
EP0719333B1 (de) 2005-01-05
CN1414018A (zh) 2003-04-30

Similar Documents

Publication Publication Date Title
DE69434221D1 (de) Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen
WO1996040766A3 (en) Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
DK0833649T3 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf
ATE212378T1 (de) Stressproteine und ihre verwendung
DK1032662T3 (da) Fremgangsmåder og sammensætninger til immunmodulation
EP1264890A3 (de) Plasmodium vivax Blutphaseantigene, dagegen gerichtete Antikörper und diagnostische Verfahren
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
WO2002011756A3 (en) Anti-plasmodium compositions and methods of use
DE69026022D1 (de) Membrane hergestellt aus Copolymeren von Polyimiden und aliphatischen Polyestern .
ATE388162T1 (de) Verfahren zur beseitigung von viren
DK124087D0 (da) Immunogent peptidantigen svarende til plasmodium vivax circumsporozoitprotein
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ATE64957T1 (de) Klonieren von dna fuer protozoenantigene.
ATE171710T1 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
GR3036782T3 (en) Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.
DE69433400D1 (de) Neue proteine von parasitischen würmern
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
NO920777L (no) Anti-thrombinpolypeptider
ATE374246T1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
WO2004044167A3 (en) Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
DK0723552T3 (da) Oligopeptider afledt af fragmenter af C-reaktivt protein
WO1995008631A3 (en) Target antigens of transmission blocking antibodies for malaria parasites
BR0008285A (pt) Vacina contra malária, polipeptìdeo, e seus usos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties